The U.S. Food and Drug Administration (FDA) has approved a innovative process using cheesecloth and banana peels from a specific Taiwanese banana variety. This breakthrough targets insomnia, anxiety, and depression through a natural dietary supplement.
Insomnia affects millions as a prevalent sleep disorder, prompting ongoing searches for effective remedies. Unusual solutions, like destination-free sleep buses in Hong Kong, highlight the demand. Anxiety and depression remain major concerns; a 2020 study linked adolescent sleep issues to heightened adult depression risk.
The FDA recently validated a banana-derived remedy to address insomnia, anxiety, and depression simultaneously. Per a November 1, 2021 press release, Taiwanese firm TCI Co., Ltd. developed this after years of research into banana-based therapies.
The FDA cleared a Taiwanese banana variety for U.S. export due to its therapeutic potential. TCI's supplement uses stamens (plant male reproductive parts) and peels, not the fruit. These contain compounds akin to those in certain anxiolytics.
TCI patented the ultrasonic cold extraction process, dubbed Happy Banana. Lab tests showed reduced anxiety in subjects, earning a gold medal at the 2021 Geneva Inventions Fair.
Banana peels support brain production of serotonin and melatonin, enhancing tryptophan metabolism genes for mood regulation. Stamens help lower prostate hypertrophy risks.
